ornithine has been researched along with Anemia, Sickle Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro, O; Gladwin, MT; Harris, A; Hauser, KP; Kato, G; Little, JA; Machado, R; Maric, I; Martyr, SE; Morris, CR; Suh, JH; Taylor, J | 1 |
| Brown, M; Duckworth, L; Froyen, M; Gauger, C; Kissoon, N; Murphy, S; Sandler, E; Sullivan, KJ | 1 |
| Cannon, RO; Coles, WA; Csako, G; Gladwin, MT; Ognibene, FP; Panza, JA; Reiter, CD; Schechter, AN; Schenke, WH; Waclawiw, MA | 1 |
| Claster, S; Hagar, W; Kepka-Lenhart, D; Kuypers, FA; Machado, L; Morris, CR; Morris, SM; Van Warmerdam, J; Vichinsky, EP | 1 |
| Blackwelder, WC; Gladwin, MT; Hazen, SL; Kato, GJ; Morris, CR; Morris, SM; Poljakovic, M; Sachdev, V; Vichinsky, EP; Wang, X | 1 |
| Levy, HL | 1 |
1 review(s) available for ornithine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Genetic screening.
Topics: Amino Acid Metabolism, Inborn Errors; Anemia, Sickle Cell; Arginine; Carbohydrate Metabolism, Inborn Errors; Cystinuria; Erythrocytes; Fanconi Syndrome; Galactosemias; Genetics, Population; Glucosephosphate Dehydrogenase; Glycine; Hartnup Disease; Heterozygote; Histidine; Homocystine; Humans; Lysine; Maple Syrup Urine Disease; Mass Screening; Methods; Ornithine; Phenylalanine; Phenylketonurias; Succinates; Tyrosine | 1973 |
3 trial(s) available for ornithine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
Topics: Acute Chest Syndrome; Acute Disease; Administration, Oral; Adolescent; Anemia, Sickle Cell; Arginine; Aspartic Acid; Breath Tests; Child; Citrulline; Female; Glutamic Acid; Humans; Male; Nitrates; Nitric Oxide; Nitrites; Ornithine; Young Adult | 2010 |
Divergent nitric oxide bioavailability in men and women with sickle cell disease.
Topics: Acetylcholine; Adult; Anemia, Sickle Cell; Biological Availability; Biomarkers; Black People; Blood Pressure; Creatinine; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Hemodynamics; Humans; Hydroxyurea; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Ornithine; Regional Blood Flow; Sex Factors; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2003 |
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
Topics: Administration, Oral; Adolescent; Adult; Amino Acids; Anemia, Sickle Cell; Arginase; Arginine; Biological Availability; Case-Control Studies; Echocardiography; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitric Oxide; Ornithine; Oximetry; Pulmonary Wedge Pressure; Treatment Outcome | 2003 |
2 other study(ies) available for ornithine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy.
Topics: Adult; Anemia, Sickle Cell; Arginase; Arginine; beta-Globins; Citrulline; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Fetal Hemoglobin; Humans; Hydroxyurea; Male; Middle Aged; Ornithine; Phosphodiesterase Inhibitors; Piperazines; Purines; Reticulocyte Count; Sildenafil Citrate; Sulfones | 2009 |
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
Topics: Adult; Aged; Amino Acids; Anemia, Sickle Cell; Arginase; Arginine; Case-Control Studies; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitric Oxide; Ornithine; Proportional Hazards Models | 2005 |